Showing results (41-50 of 844) with videos related to
Sort By:
Pageof 85
Journal of Science and Medicine in Sport|August 14, 2017
Physical activity domains and cognitive function over three years in older adults with subjective memory complaints: Secondary analysis from the MAPT trialPhilipe de Souto Barreto, Sandrine Andrieu, Yves Rolland, et al.Journal of Alzheimer'S Disease : JAD|August 1, 2014
Impact of a therapeutic educational program on quality of life in Alzheimer's disease: results of a pilot studyHélène Villars, Charlotte Dupuy, Amélie Perrin, et al.Presse Medicale (Paris, France : 1983)|November 4, 2004
[Physical restraint in old people's homes. Evaluation of skills following specific training]Julie Biga, Fati Nourhashémi, Sandrine Andrieu, et al.Canadian Journal of Diabetes|September 12, 2016
Effects of Diabetes Mellitus on Cognitive Decline in Patients with Alzheimer Disease: A Systematic ReviewJun Li, Matteo Cesari, Fei Liu, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 8, 2017
Exercise Training for Preventing Dementia, Mild Cognitive Impairment, and Clinically Meaningful Cognitive Decline: A Systematic Review and Meta-analysisPhilipe de Souto Barreto, Laurent Demougeot, Bruno Vellas, et al.Translational Neuroscience|February 25, 2021
Retraction of: Identification of biological markers for better characterization of older subjects with physical frailty and sarcopeniaBertrand Fougère, Bruno Vellas, Gabor Abellan van Kan, et al.Translational Neuroscience|January 27, 2017
Identification of biological markers for better characterization of older subjects with physical frailty and sarcopeniaBertrand Fougère, Bruno Vellas, Gabor Abellan van Kan, et al.The Lancet. Neurology|April 19, 2008
Endpoints for trials in Alzheimer's disease: a European task force consensusBruno Vellas, Sandrine Andrieu, Cristina Sampaio, et al.Current Protein & Peptide Science|March 21, 2017
Redox Systems, Antioxidants and SarcopeniaBertrand Fougere, Gabor Abellan van Kan, Bruno Vellas, et al.CNS Drugs|June 30, 2004
What are the treatment options for patients with severe Alzheimer's disease?Thierry Voisin, Emma Reynish, Florence Portet, et al.Pageof 85